Xiaodong Wang, Director at BeOne Medicines Ltd. (ONC), sold 31,028 shares at $356.97 ($11.3M) on 2026-09-28, disclosed to the SEC on 2026-09-30.
Scheduled sale ($11.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $356.97 | 160 | $57K | 0.5% |
| 2 | $358.71 | 120 | $43K | 0.4% |
| 3 | $359.16 | 40 | $14K | 0.1% |
| 4 | $361.05 | 2,241 | $809K | 7.1% |
| 5 | $362.17 | 4,239 | $1.5M | 13.6% |
| 6 | $363.10 | 3,499 |
| $1.3M |
| 11.2% |
| 7 | $364.07 | 3,419 | $1.2M | 11.0% |
| 8 | $365.85 | 2,047 | $749K | 6.6% |
| 9 | $366.58 | 14,525 | $5.3M | 47.0% |
| 10 | $367.23 | 738 | $271K | 2.4% |
| Total | $364.79 avg | 31,028 | $11.3M | 100% |
| Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |
| BGNE | SELL | 2025-04-16 | $20.3M | — | Filing → |